Compile Data Set for Download or QSAR
Report error Found 67 of ic50 data for polymerid = 50001280
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110881(4-{2-Oxo-3-[4-(5-phenyl-pentylsulfanyl)-phenoxy]-p...)
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110846(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110859({4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-phenyl}-...)
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110854(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-3-nitro-b...)
Affinity DataIC50: 20nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110873(4-[3-(4-Dodecyloxy-phenoxy)-2-oxo-propoxy]-benzoic...)
Affinity DataIC50: 26nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110875(5-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-pentanoic...)
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110846(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110865(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxymethyl]-ben...)
Affinity DataIC50: 35nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110872(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxymethyl]-ben...)
Affinity DataIC50: 40nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110884(4-[3-(4-Octyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 46nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110879(4-{2-Oxo-3-[4-(5-phenyl-pentyloxy)-phenoxy]-propox...)
Affinity DataIC50: 48nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110888(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 50nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110860({3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-phenyl}-...)
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110853({3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-phenoxy}...)
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110863(5-[3-(4-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-pe...)
Affinity DataIC50: 70nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110871(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-3-methoxy...)
Affinity DataIC50: 74nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110881(4-{2-Oxo-3-[4-(5-phenyl-pentylsulfanyl)-phenoxy]-p...)
Affinity DataIC50: 80nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110854(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-3-nitro-b...)
Affinity DataIC50: 120nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110859({4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-phenyl}-...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110865(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxymethyl]-ben...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110878(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-bu...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110853({3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-phenoxy}...)
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110889(4-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-butyric a...)
Affinity DataIC50: 240nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110880(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-pr...)
Affinity DataIC50: 270nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110857(4-[3-(4-Hexyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 280nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110877(3-[2-Oxo-3-(4-tetradecyloxy-phenoxy)-propylsulfany...)
Affinity DataIC50: 400nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110884(4-[3-(4-Octyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 410nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110879(4-{2-Oxo-3-[4-(5-phenyl-pentyloxy)-phenoxy]-propox...)
Affinity DataIC50: 460nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110886(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propane-1-sulfonyl...)
Affinity DataIC50: 500nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110850({3-[3-(4-Decyloxy-benzyloxy)-2-oxo-propoxy]-phenyl...)
Affinity DataIC50: 660nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110855(3-[4-(4-Decyloxy-phenyl)-2-oxo-butoxy]-benzoic aci...)
Affinity DataIC50: 690nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110883(3-[3-(3-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-pr...)
Affinity DataIC50: 700nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50059523(Arachidonyltrifluoromethane | (6Z,9Z,12Z,15Z)-1,1,...)
Affinity DataIC50: 800nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110876(4-{3-[4-(4-Nitro-benzyloxy)-phenoxy]-2-oxo-propoxy...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110882(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propane-1-sulfinyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110874(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propoxy]-propionic...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110868(4-{3-Oxo-4-[4-(5-phenyl-pentylsulfanyl)-phenoxy]-b...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110847(4-[3-(4-Decyloxy-phenoxy)-2-hydroxy-propoxy]-benzo...)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110849(3-[3-(2-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-pr...)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110858([3-(4-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-acet...)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110848(3-[3-(4-Decyloxy-phenoxy)-propylsulfanyl]-propioni...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110855(3-[4-(4-Decyloxy-phenyl)-2-oxo-butoxy]-benzoic aci...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110867(4-[3-(4-Benzyloxy-phenoxy)-2-oxo-propoxy]-benzoic ...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110880(3-[3-(4-Decyloxy-phenoxy)-2-oxo-propylsulfanyl]-pr...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110852(3-{3-[4-(Naphthalen-2-ylmethoxy)-phenoxy]-2-oxo-pr...)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110851(4-{3-[4-(4-Methoxy-benzyloxy)-phenoxy]-2-oxo-propo...)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110850({3-[3-(4-Decyloxy-benzyloxy)-2-oxo-propoxy]-phenyl...)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110890(3-[3-(4-Decyloxy-phenoxy)-2-hydroxy-propylsulfanyl...)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110870(4-[3-(4-Butoxy-phenoxy)-2-oxo-propoxy]-benzoic aci...)
Affinity DataIC50: 4.30E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytosolic phospholipase A2 beta(Human)
Astrazeneca R&D Charnwood

Curated by ChEMBL
LigandPNGBDBM50110857(4-[3-(4-Hexyloxy-phenoxy)-2-oxo-propoxy]-benzoic a...)
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: